Abstract
Objective
To evaluate the biodistribution of radiation-absorbed doses of 13N-ammonia in healthy people.
Methods
Five healthy human subjects underwent whole-body PET and CT scans after injection of 555–740 MBq of 13N-ammonia. Five serial dynamic emission scans in each healthy volunteer were acquired. Regions of interest were drawn on the CT image and transferred to the corresponding transverse PET slice. Estimates of the radiation-absorbed doses were calculated using the medical internal radiation dosimetry method.
Results
The highest concentrations of 13N-ammonia were found in the heart and liver, followed by pancreas, brain, spleen and stomach. The highest absorbed organ doses were to the heart wall (7.14E−03 ± 3.63E−03 mGy/MBq) and kidneys (6.02E−03 ± 3.53E−03 mGy/MBq). The effective dose (ED) was 6.58E−03 ± 1.23E−03 mSv/MBq.
Conclusions
With these new estimates for 13N-ammonia dosimetry, the results for Chinese people were not appreciably different from those of the previous study performed with old devices. As one of the most important myocardial perfusion PET tracers, the whole-body 13N-ammonia PET appears to be safe for humans, yielding a relatively modest radiation burden that would allow multiple PET studies on the same subject per year.
Similar content being viewed by others
References
Clark JC, Aigbirdhio FI. Chemistry of nitrogen-13 and oxygen-15. In: Welch MJ, Redvanly CS, editors. Handbook of Radiopharmaceuticals. Chichester: Wiley; 2003. p. 119–40.
Phelps ME, Hoffman EJ, Raybaud C. Factors which affect cerebral uptake and retention of 13 NH3. Stroke. 1977;8:694–702.
Schelbert HR. PET studies of the heart. In: Phelps ME, Mazziota JC, Schelbert HR, editors. Positron emission tomography and autoradiography. New York: Raven Press; 1986. p. 581–662.
Shi X, Zhang X, Yi C, Liu Y, He Q. [13N]Ammonia positron emission tomographic/computed tomographic imaging targeting glutamine synthetase expression in prostate cancer. Mol Imaging. 2014;13:1–10.
Lockwood AH. Absorbed doses of radiation after an intravenous injection of N-13 ammonia in man: concise communication. J Nucl Med. 1980;21:276–8.
Stabin MG. Radiopharmaceuticals for nuclear cardiology: radiation dosimetry, uncertainties, and risk. J Nucl Med. 2008;49:1555–63.
Krasikova RN, Fedorova OS, Korsakov MV, Bennington BI, Berridge MS. Improved [N-13]ammonia yield from the proton irradiation of water using methane gas. Appl Radiat Isot. 1999;51:395–401.
Sgouros G. Dosimetry of internal emitters. J Nucl Med. 2005;46:18S–27S.
Cropley VL, Fujita M, Musachio JL, Hong J, Ghose S, Sangare J, et al. Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans. J Nucl Med. 2006;47:100–4.
Mejia AA, Nakamura T, Masatoshi I, Hatazawa J, Masaki M, Watanuki S. Estimation of absorbed doses in human due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies. J Nucl Med. 1991;32:699–709.
Seltzer MA, Jahan SA, Sparks R, Stout DB, Satyamurthy N, Dahlbom M, et al. Radiation dose estimates in humans for C-11-acetate whole-body PET. J Nucl Med. 2004;45:1233–6.
Huang T, Wang H, Tang G, Liang X, Deng H, Yi C, et al. Human radiation dose estimation of 11C-CFT using whole-body PET. Clin Nucl Med. 2012;37:1159–62.
Cristy M, Eckerman KF. Specific absorbed fractions of energy at various ages from internal photon sources. Oak Ridge: Oak Ridge National Laboratory; 1987.
Tang G, Wang M, Tang X, Luo L, Gan M. Pharmacokinetics and radiation dosimetry estimation of O-(2-[18F]fluoroethyl)-l-tyrosine as oncologic PET tracer. Appl Radiat Isot. 2003;58(2):219–25.
Coffey JL, Watson EE. Calculation dose from remaining body activity: a comparison of two methods. Med Phys. 1979;6:307–8.
International Commission on Radiological Protection. ICRP Publication 60: 1990 Recommendations of the International Commission on Radiological Protection. Oxford: Pergamon; 1991.
Keiding S, Sørensen M, Bender D, Munk OL, Ott P, Vilstrup H. Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography. Hepatology. 2006;43:42–50.
Cooper AJ. 13N as a tracer for studying glutamate metabolism. Neurochem Int. 2011;59:456–64.
Lockwood AH. Positron emission tomography in the study of hepatic encephalopathy. Metab Brain Dis. 2002;17:431–5.
Lie-Venema H, Hakvoort TB, van Hemert FJ, Moorman AF, Lamers WH. Regulation of the spatiotemporal pattern of expression of the glutamine synthetase gene. Prog Nucleic Acid Res Mol Biol. 1998;61:243–308.
Eisenberg D, Almassy RJ, Janson CA, Chapman MS, Suh SW, Cascio D, et al. Some evolutionary relationships of the primary biological catalysts glutamine synthetase and RuBisCO. Cold Spring Harb Symp Quant Biol. 1987;52:483–90.
Krajewski WW, Collins R, Holmberg-Schiavone L, Jones TA, Karlberg T, Mowbray SL. Crystal structures of mammalian glutamine synthetases illustrate substrate-induced conformational changes and provide opportunities for drug and herbicide design. J Mol Biol. 2008;375:317–28.
Lockwood AH, McDonald JM, Reiman RE, Gelbard AS, Laughlin JS, Duffy TE, et al. The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J Clin Invest. 1979;63:449–60.
International Commission on Radiological Protection. ICRP publication 103: The 2007 Recommendations of the International Commission on Radiological Protection. Oxford: Pergamon; 2007.
CFR-Code of Federal Regulations Title 21, part 361. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=361&showFR=1.
Acknowledgments
The authors wish to thank Professor Ganghua Tang who provided the generous gift of a copy of the S value tables. This study was supported by the 973 program No. 2015CB755500 and the National Natural Science Foundation of China (81271599).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No potential conflicts of interest were disclosed.
Rights and permissions
About this article
Cite this article
Yi, C., Yu, D., Shi, X. et al. Biodistribution and estimation of radiation-absorbed doses in humans for 13N-ammonia PET. Ann Nucl Med 29, 810–815 (2015). https://doi.org/10.1007/s12149-015-1012-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12149-015-1012-4